ArticleBioactive materials2025

Dual-pathway targeted therapy for Parkinson's disease: Biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.